Kotobuki Pharmaceutical Co Ltd - Company Review
Kotobuki Pharmaceutical Co Ltd - Company ReviewSummary
Kotobuki Pharmaceutical Co Ltd (Kotobuki Pharma) is a manufacturer and distributor of prescription drugs. The company provides traditional extracts medicine and synthetic chemical drug. Its products include cagudalin, cetirizine hydrochloride, azuloxa, binograc, dibeton S, donepezil hydrochloride OD, epinastine and fenofibrate. Kotobuki Pharma also provides hormitol, kirigamil, marzulene, muirodine, paroxetine, olopatadine hydrochloride, sarpogrelate hydrochloride, sobulaline, and temocapril hydrochloride, among others. The company provides its products in the dosage forms of tablets, coated tablets, solution, capsules and granules. It markets its products through its network of distributors. The company operates in Nagano, Tokyo and Ibaraki, Japan. Kotobuki Pharma is headquartered in Nagano, Japan.
This comprehensive company report of Kotobuki Pharmaceutical Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.